{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:29Z","timestamp":1788480509851,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008316","name":"Baden-W\u00fcrttemberg Stiftung","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100008316","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New National Excellence Program of the Ministry of Human Capacities of Hungary","award":["\u00daNKP-18-2-I-SE-100"],"award-info":[{"award-number":["\u00daNKP-18-2-I-SE-100"]}]},{"name":"Stephen W. Kuffler Research Foundation","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["NVKP_16-1-2016-0017"],"award-info":[{"award-number":["NVKP_16-1-2016-0017"]}]},{"name":"Higher Education Institutional Excellence Programme of the Ministry of Human Capacities of Hungary","award":["EFOP-3.6.3-VEKOP-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.3-VEKOP-16-2017-00009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1881-8","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T13:04:44Z","timestamp":1555419884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Acute canagliflozin treatment protects against in vivo myocardial ischemia\u2013reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7728-4775","authenticated-orcid":false,"given":"Alex Ali","family":"Sayour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Korkmaz-Ic\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakkanan","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor Nabil","family":"Sayour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Ol\u00e1h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1lm\u00e1n","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Brune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Benk\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter M\u00e1ria","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Karck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Radovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"22","key":"1881_CR1","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"7","key":"1881_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644\u201357.","journal-title":"N Engl J Med"},{"issue":"4","key":"1881_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.117.032038","volume":"137","author":"KW Mahaffey","year":"2018","unstructured":"Mahaffey KW, Neal B, Perkovic V, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Fabbrini E, Sun T, Li Q, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (canagliflozin cardiovascular assessment study). Circulation. 2018;137(4):323\u201334.","journal-title":"Circulation"},{"issue":"6","key":"1881_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2213-8587(17)30314-5","volume":"6","author":"RM Bell","year":"2018","unstructured":"Bell RM, Yellon DM. SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection. Lancet Diabetes Endocrinol. 2018;6(6):435\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1881_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.040","author":"TA Zelniker","year":"2018","unstructured":"Zelniker TA, Braunwald E. Cardiac and renal effects of sodium\u2013glucose co-transporter 2 inhibitors in diabetes: JACC state-of-the-art review. J Am Coll Cardiol. 2018. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.06.040\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1881_CR6","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/db16-0058","volume":"65","author":"SA Hawley","year":"2016","unstructured":"Hawley SA, Ford RJ, Smith BK, Gowans GJ, Mancini SJ, Pitt RD, Day EA, Salt IP, Steinberg GR, Hardie DG. The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels. Diabetes. 2016;65(9):2784\u201394.","journal-title":"Diabetes"},{"issue":"3","key":"1881_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","volume":"61","author":"L Uthman","year":"2018","unstructured":"Uthman L, Baartscheer A, Bleijlevens B, Schumacher CA, Fiolet JWT, Koeman A, Jancev M, Hollmann MW, Weber NC, Coronel R, et al. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)\/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation. Diabetologia. 2018;61(3):722\u20136.","journal-title":"Diabetologia"},{"issue":"9","key":"1881_CR8","doi-asserted-by":"publisher","first-page":"L1027","DOI":"10.1152\/ajplung.00167.2015","volume":"309","author":"Y Han","year":"2015","unstructured":"Han Y, Cho YE, Ayon R, Guo R, Youssef KD, Pan M, Dai A, Yuan JX, Makino A. SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery. Am J Physiol Lung Cell Mol Physiol. 2015;309(9):L1027\u201336.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1881_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.vph.2018.06.006","volume":"109","author":"M El-Daly","year":"2018","unstructured":"El-Daly M, Pulakazhi Venu VK, Saifeddine M, Mihara K, Kang S, Fedak PWM, Alston LA, Hirota SA, Ding H, Triggle CR, et al. Hyperglycaemic impairment of PAR2-mediated vasodilation: prevention by inhibition of aortic endothelial sodium\u2013glucose-co-transporter-2 and minimizing oxidative stress. Vasc Pharmacol. 2018;109:56\u201371.","journal-title":"Vasc Pharmacol"},{"issue":"6","key":"1881_CR10","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"issue":"3","key":"1881_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.carrev.2005.07.001","volume":"6","author":"SA Samsamshariat","year":"2005","unstructured":"Samsamshariat SA, Samsamshariat ZA, Movahed MR. A novel method for safe and accurate left anterior descending coronary artery ligation for research in rats. Cardiovasc Revasc Med. 2005;6(3):121\u20133.","journal-title":"Cardiovasc Revasc Med"},{"issue":"1","key":"1881_CR12","doi-asserted-by":"publisher","first-page":"H124","DOI":"10.1152\/ajpheart.00108.2013","volume":"305","author":"T Radovits","year":"2013","unstructured":"Radovits T, Olah A, Lux A, Nemeth BT, Hidi L, Birtalan E, Kellermayer D, Matyas C, Szabo G, Merkely B. Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure\u2013volume analysis. Am J Physiol Heart Circ Physiol. 2013;305(1):H124\u201334.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20133","key":"1881_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejphar.2009.05.020","volume":"615","author":"S Korkmaz","year":"2009","unstructured":"Korkmaz S, Radovits T, Barnucz E, Neugebauer P, Arif R, Hirschberg K, Loganathan S, Seidel B, Karck M, Szabo G. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta. Eur J Pharmacol. 2009;615(1\u20133):155\u201362.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1881_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/cpdd.162","volume":"4","author":"D Devineni","year":"2015","unstructured":"Devineni D, Murphy J, Wang SS, Stieltjes H, Rothenberg P, Scheers E, Mamidi RN. Absolute oral bioavailability and pharmacokinetics of canagliflozin: a microdose study in healthy participants. Clin Pharmacol Drug Dev. 2015;4(4):295\u2013304.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"3","key":"1881_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0014-5793(98)01705-0","volume":"443","author":"ZP Chen","year":"1999","unstructured":"Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999;443(3):285\u20139.","journal-title":"FEBS Lett"},{"issue":"3","key":"1881_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"M Kosiborod","year":"2017","unstructured":"Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jorgensen ME, Thuresson M, et al. Lower risk of heart failure and death in patients initiated on sodium\u2013glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium\u2013glucose cotransporter-2 inhibitors). Circulation. 2017;136(3):249\u201359.","journal-title":"Circulation"},{"issue":"2","key":"1881_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","volume":"1","author":"J Chen","year":"2010","unstructured":"Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther. 2010;1(2):57\u201392.","journal-title":"Diabetes Ther"},{"issue":"10","key":"1881_CR18","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","volume":"5","author":"LA Villani","year":"2016","unstructured":"Villani LA, Smith BK, Marcinko K, Ford RJ, Broadfield LA, Green AE, Houde VP, Muti P, Tsakiridis T, Steinberg GR. The diabetes medication canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration. Mol Metab. 2016;5(10):1048\u201356.","journal-title":"Mol Metab"},{"issue":"1","key":"1881_CR19","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","volume":"8","author":"SJ Mancini","year":"2018","unstructured":"Mancini SJ, Boyd D, Katwan OJ, Strembitska A, Almabrouk TA, Kennedy S, Palmer TM, Salt IP. Canagliflozin inhibits interleukin-1beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms. Sci Rep. 2018;8(1):5276.","journal-title":"Sci Rep"},{"issue":"11","key":"1881_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/CIRCRESAHA.117.309633","volume":"120","author":"IP Salt","year":"2017","unstructured":"Salt IP, Hardie DG. AMP-activated protein kinase: an ubiquitous signaling pathway with key roles in the cardiovascular system. Circ Res. 2017;120(11):1825\u201341.","journal-title":"Circ Res"},{"issue":"1","key":"1881_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2011.03.003","volume":"51","author":"AS Kim","year":"2011","unstructured":"Kim AS, Miller EJ, Wright TM, Li J, Qi D, Atsina K, Zaha V, Sakamoto K, Young LH. A small molecule AMPK activator protects the heart against ischemia\u2013reperfusion injury. J Mol Cell Cardiol. 2011;51(1):24\u201332.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1881_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2337\/db07-1098","volume":"57","author":"JW Calvert","year":"2008","unstructured":"Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes. 2008;57(3):696\u2013705.","journal-title":"Diabetes"},{"issue":"3","key":"1881_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0003-4975(95)00423-I","volume":"60","author":"AM Lefer","year":"1995","unstructured":"Lefer AM. Attenuation of myocardial ischemia\u2013reperfusion injury with nitric oxide replacement therapy. Ann Thorac Surg. 1995;60(3):847\u201351.","journal-title":"Ann Thorac Surg"},{"issue":"36","key":"1881_CR24","doi-asserted-by":"publisher","first-page":"32552","DOI":"10.1074\/jbc.M204512200","volume":"277","author":"MH Zou","year":"2002","unstructured":"Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem. 2002;277(36):32552\u20137.","journal-title":"J Biol Chem"},{"issue":"10","key":"1881_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nm1295","volume":"11","author":"R Shibata","year":"2005","unstructured":"Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. Adiponectin protects against myocardial ischemia\u2013reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005;11(10):1096\u2013103.","journal-title":"Nat Med"},{"issue":"6","key":"1881_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia\u2013reperfusion injury in mouse heart. Circulation. 2000;101(6):660\u20137.","journal-title":"Circulation"},{"issue":"3","key":"1881_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0008-6363(00)00078-X","volume":"47","author":"NS Dhalla","year":"2000","unstructured":"Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia\u2013reperfusion injury. Cardiovasc Res. 2000;47(3):446\u201356.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1881_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/j.1476-5381.2012.01895.x","volume":"166","author":"J Lempiainen","year":"2012","unstructured":"Lempiainen J, Finckenberg P, Levijoki J, Mervaala E. AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney. Br J Pharmacol. 2012;166(6):1905\u201315.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"1881_CR29","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1006\/jmcc.2001.1454","volume":"33","author":"J Chen","year":"2001","unstructured":"Chen J, Henderson GI, Freeman GL. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia\/reperfused rat heart. J Mol Cell Cardiol. 2001;33(11):1919\u201327.","journal-title":"J Mol Cell Cardiol"},{"issue":"1 Pt 2","key":"1881_CR30","first-page":"H14","volume":"269","author":"IE Blasig","year":"1995","unstructured":"Blasig IE, Grune T, Schonheit K, Rohde E, Jakstadt M, Haseloff RF, Siems WG. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol. 1995;269(1 Pt 2):H14\u201322.","journal-title":"Am J Physiol"},{"issue":"1","key":"1881_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12933-017-0511-0","volume":"16","author":"M Pfeifer","year":"2017","unstructured":"Pfeifer M, Townsend RR, Davies MJ, Vijapurkar U, Ren J. Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis. Cardiovasc Diabetol. 2017;16(1):29.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1881-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1881-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1881-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T23:21:08Z","timestamp":1586906468000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1881-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1881-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"127"}}